Improved Glycemic Control and Lipid Profile in a Randomized Study of Pioglitazone Compared with Acarbose in Patients with Type 2 Diabetes Mellitus

By Göke B.  

Treatments in Endocrinology, Vol. 1, Iss. 5, 2002-01 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

By Charbonnel B.   Steinberg H.   Eymard E.   Xu L.   Thakkar P.   Prabhu V.   Davies M.   Engel S.  

Diabetologia, Vol. 56, Iss. 7, 2013-07 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite

Exercise and Postprandial Glycemic Control in Type 2 Diabetes

By  

Current Diabetes Reviews, Vol. 12, Iss. 3, 2016-07 ,pp. : 199-210

Bentham Science Publishers

Access to resources Recommend Favorite

A New Preventive Strategy for Hypoglycemia Incorporating Added Food Diet in Patients with Type 2 Diabetes Who Received Sitagliptin Therapy

By Meguro Shu   Sano Motoaki   Kawai Toshihide   Matsuhashi Tomohiro   Mogi Satoshi   Fukuda Keiichi   Itoh Hiroshi   Suzuki Yoshihiko  

Endocrine Research, Vol. 37, Iss. 4, 2012-11 ,pp. : 175-181

Informa Healthcare

Access to resources Recommend Favorite

Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes

By Arnetz Lisa   Dorkhan Mozhgan   Alvarsson Michael   Brismar Kerstin   Ekberg Neda  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite